Press "esc" to clear
Go to Advanced Search

Showing results

110 of 285
Embargo will expire:
23-Jan-2019 5:00 PM EST
Released to reporters:
22-Jan-2019 3:10 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 23-Jan-2019 5:00 PM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

JesseWisniewskiPharmD.jpg

Article ID: 706633

Cedars-Sinai Pharmacists Play Key Role in Transforming Clinical Practice

Cedars-Sinai

When patients fail to take prescribed medications—or don't use them the right way—they risk return trips to the hospital and cost the U.S. healthcare system more than $100 billion a year. Older hospital patients are most susceptible to drug-related problems that can lead to readmissions or even death. To help these individuals get the right medications and take them correctly after discharge, Cedars-Sinai has embedded pharmacists in the care teams treating certain high-risk patients. Medication lists are double-checked by a pharmacist for errors prior to discharge, and patients are sent home with their prescription drugs after being counseled on how to take them properly.

Released:
21-Jan-2019 9:00 AM EST

Article ID: 706333

New Leukemia Drug is More Effective and Easier to Use

Loyola University Health System

A landmark study has found that a newer targeted drug is significantly more effective than standard therapy for treating elderly patients with chronic lymphocytic leukemia (CLL). The drug, ibrutinib, attacks cancer cells without damaging normal cells, thus causing fewer side effects.

Released:
10-Jan-2019 7:05 PM EST

Article ID: 706061

Opioids Fueled a Doubling of Suicides and Overdoses in the U.S.

Michigan Medicine - University of Michigan

Suicides and drug overdoses kill American adults at twice the rate today as they did just 17 years ago, and opioids are a key contributor to that rise, according to a new review and analysis. Reversing this deadly double trend will take investment in programs that have been proven to prevent and treat opioid addiction, the researchers say.

Released:
7-Jan-2019 9:50 AM EST
  • Embargo expired:
    26-Dec-2018 5:00 PM EST

Article ID: 705798

For Patients with Kidney Disease, Genetic Testing May Soon Be Routine

Columbia University Irving Medical Center

DNA sequencing can be used to identify the underlying genetic cause of many rare types of chronic kidney disease, leading to better treatment, finds a new study from Columbia University.

Released:
21-Dec-2018 10:05 AM EST
  • Embargo expired:
    19-Dec-2018 5:00 PM EST

Article ID: 705491

Targeted Treatment Slows Progression of Rare Connective Tissue Tumor

Columbia University Irving Medical Center

About 80 percent of patients with desmoid tumors had no progression of their tumors over a two-year period while taking a drug called sorafenib during a phase 3 clinical trial.

Released:
14-Dec-2018 11:05 AM EST
  • Embargo expired:
    19-Dec-2018 5:00 PM EST

Article ID: 705505

How Children & Teens Die in America: Study Reveals the Widespread & Persistent Role of Firearms

Michigan Medicine - University of Michigan

America lost 20,360 children and teens in 2016 -- 60 percent of them to preventable injuries, a new study shows. But while death rates from the top cause – motor vehicle crashes – have declined steadily since 1999, rates from the second-leading cause - firearms - have gone up. It’s the first time all causes of child and adolescent death have been tallied by both mechanism and intent.

Released:
14-Dec-2018 1:05 PM EST
Aedes_aegypti_during_blood_meal646x363.jpg
  • Embargo expired:
    12-Dec-2018 5:00 PM EST

Article ID: 705020

15 percent of babies exposed to Zika before birth had severe abnormalities in first 18 months of life

University of California, Los Angeles (UCLA), Health Sciences

By age 12 to 18 months, 6.25% of children exposed to Zika during their mothers’ pregnancies had eye abnormalities, 12.2% had hearing problems, and 11.7% had severe delays in language, motor skills and/or cognitive function. In all, 14.5% had at least one of the three abnormalities.

Released:
5-Dec-2018 8:05 PM EST
  • Embargo expired:
    1-Dec-2018 12:00 PM EST

Article ID: 704664

Global Trial Shows CAR T Therapy Can Lead to Durable Remissions in Non-Hodgkin’s Lymphoma

Perelman School of Medicine at the University of Pennsylvania

In an update to a global clinical trial stretching from Philadelphia to four continents, the chimeric antigen receptor (CAR) T cell therapy Kymriah® (tisagenlecleucel, formerly CTL019) led to long-lasting remissions in patients with relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL).

Released:
30-Nov-2018 8:30 AM EST
DSC06541.JPG
  • Embargo expired:
    1-Dec-2018 12:00 PM EST

Article ID: 704734

CAR-T cell update: therapy improves outcomes for patients with B-cell lymphoma

University of Chicago Medical Center

An international phase-2 trial of a CAR-T cell therapy—to be published on-line Dec. 1 in the New England Journal of Medicine (and presented at the ASH annual meeting in San Diego)—found that 52% of patients responded favorably to the therapy; 40% had a complete response and 12% had a partial response. One year later, 65% of those patients were relapse-free, including 79% of complete responders. The median progression-free survival “has not been reached.”

Released:
30-Nov-2018 4:00 PM EST

Showing results

110 of 285

Chat now!